Vitreous STMN2 levels reflect TDP-43-associated neurodegeneration in postmortem eyes and brains

Stathmin-2 (STMN2) levels decline in brains with transactive response DNA binding protein-43 (TDP-43) inclusions. TDP-43-related changes could extend to ocular structures, although vitreous STMN2 levels remain uncharacterized. This exploratory study analyzed 72 post-mortem brains and eyes depending on the presence or absence of TDP-43 inclusions in the brain and across neuropathological diagnostic groups (Alzheimer's disease [AD], chronic traumatic encephalopathy [CTE], AD and CTE, or neither). Results showed decreased vitreous STMN2 levels in TDP-43-positive cases but no association with diagnostic groups. Vitreous STMN2 was correlated with vitreous neurofilament light chain. Diminished vitreous STMN2 levels might indicate TDP-43-associated neurodegeneration.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease Reports
Published
2025-01-01
DOI
https://doi.org/10.1177/25424823251392553
Primary Topic
Cerebrospinal fluid and hydrocephalus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Vitreous STMN2 levels reflect TDP-43-associated neurodegeneration in postmortem eyes and brains

Raymond Nicks, Surya Pulukuri, Thor D. Stein, Ann C. McKee et al.
Journal of Alzheimer s Disease Reports
Cerebrospinal fluid and hydrocephalus
article

Vitreous STMN2 levels reflect TDP-43-associated neurodegeneration in postmortem eyes and brains

Raymond Nicks, Surya Pulukuri, Thor D. Stein, Ann C. McKee, Manju L. Subramanian, Konstantina Sampani, Fatima Tuz‐Zahra, Daniel A. Mordes, Weiming Xia, Elizabeth Spurlock, Yorghos Tripodis, Gaoyuan Meng, Victor E. Alvarez
article en

Abstract

Stathmin-2 (STMN2) levels decline in brains with transactive response DNA binding protein-43 (TDP-43) inclusions. TDP-43-related changes could extend to ocular structures, although vitreous STMN2 levels remain uncharacterized. This exploratory study analyzed 72 post-mortem brains and eyes depending on the presence or absence of TDP-43 inclusions in the brain and across neuropathological diagnostic groups (Alzheimer's disease [AD], chronic traumatic encephalopathy [CTE], AD and CTE, or neither). Results showed decreased vitreous STMN2 levels in TDP-43-positive cases but no association with diagnostic groups. Vitreous STMN2 was correlated with vitreous neurofilament light chain. Diminished vitreous STMN2 levels might indicate TDP-43-associated neurodegeneration.

Journal of Alzheimer s Disease ReportsVol. 9
Boston University (US), Boston Medical Center (US), Joslin Diabetes Center (US), Harvard University (US), University of California, San Francisco (US), VA Boston Healthcare System (US), University of California System (US), VA New England Healthcare System (US), Geriatric Research Education and Clinical Center (US), Institute for Neurodegenerative Disorders (US)
Openalex Percentile: Top 65%
Cerebrospinal fluid and hydrocephalus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.